Close
Nordic 9Nordic 9

SLS Venture (investor - Venture Capital)

Sweden slsinvest.com
See something wrong or missing? Let us know
Offices:Stockholm

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus.

The portfolio is now managed by the Sixth AP Fund (AP6)

Average round investment:18.2M USD
Average number per year:1.0
Distribution: 2007 (1)2005 (1)
Portfolio companies: Sweden OxThera
Mostly invests in: Sweden Sweden (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SLS Venture

Name Criteria
Sweden Ratos
62%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
Sweden Recipharm Venture Fund
62%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
Norway Ferd Capital
61%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
Sweden HealthCap
61%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.6
Sweden Impilo
60%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.0
Denmark Novo A/S
60%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
United Kingdom Wellington Partners
60%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
Norway Hadean Ventures
59%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.7
Denmark Novo Seeds
59%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 3.2
Luxembourg Vesalius Biocapital Partners
57%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.7
Top